IPP Bureau
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
By IPP Bureau - April 05, 2022
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Suven Pharmaceuticals acquires Casper Pharma for Rs 155 crore
By IPP Bureau - April 05, 2022
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
BSV strengthens women's health portfolio by acquiring Tidilan brand
By IPP Bureau - April 05, 2022
It is currently available in tablet and injectable dosage forms
IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15
By IPP Bureau - April 05, 2022
The two-day event will showcase achievements and address issues pertaining to the industry
CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China
By IPP Bureau - April 04, 2022
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Radiaction Medical receives USFDA clearance for its radiation protection system
By IPP Bureau - April 04, 2022
It also secures US $ 10 million for US launch and commercialization
Novartis announces new organizational structure
By IPP Bureau - April 04, 2022
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19
By IPP Bureau - April 04, 2022
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Good microbiome and probiotics key to good health
By IPP Bureau - April 04, 2022
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
By IPP Bureau - April 04, 2022
Supply increase to help meet growing global demand
Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
By IPP Bureau - April 04, 2022
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
FirstCure, a healthcare startup that simplifies surgeries
By IPP Bureau - April 04, 2022
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
By IPP Bureau - April 04, 2022
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
International Virchow Prize for Global Health launched
By IPP Bureau - April 04, 2022
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
Siemens Healthineers expands its manufacturing footprint under PLI scheme
By IPP Bureau - April 04, 2022
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
